Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 May 2022 15:24

RNS Number : 1597K
Sensyne Health PLC
03 May 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV3J755

Issuer Name

SENSYNE HEALTH PLC

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Gatemore Capital Management LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

UK

4. Details of the shareholder

Name

City of registered office

Country of registered office

Gatemore Special Opportunities Master Fund Ltd

Grand Cayman

Cayman Islands

5. Date on which the threshold was crossed or reached

28-Apr-2022

6. Date on which Issuer notified

28-Apr-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.940000

0.000000

5.940000

9892099

Position of previous notification (if applicable)

4.390000

1.610000

6.000000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYV3J755

9892099

5.940000

Sub Total 8.A

9892099

5.940000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Gatemore Capital Management LLP as manager for Gatemore Special Opportunities Master Fund Ltd

Gatemore Special Opportunities Master Fund Ltd

5.940000

5.940000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

29-Apr-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALSDEAFAEFA
Date   Source Headline
22nd Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
21st Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
18th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
17th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Feb 20225:03 pmRNSResults of General Meeting
11th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Feb 202210:08 amRNSForm 8.5 (EPT/RI)
11th Feb 20228:12 amRNSForm 8.3 - Sensyne Health Plc
10th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
9th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Feb 20225:08 pmRNSForm 8.3 - Sensyne Health Plc
8th Feb 20223:14 pmRNSForm 8.3 - Sensyne Health PLC
8th Feb 20221:02 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Feb 20229:34 amRNSUpdate on General Meeting
7th Feb 20221:17 pmBUSForm 8.3 - Sensyne Health Ltd
7th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
4th Feb 20222:25 pmRNSForm 8.5 (EPT/NON-RI) - Sensyne Health Plc
4th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
3rd Feb 20224:49 pmRNSForm 8.5 (EPT/RI)-Sensyne Health plc Amend
3rd Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
2nd Feb 20222:24 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
2nd Feb 20228:51 amRNSForm 8.5 (EPT/RI)
1st Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
1st Feb 20228:53 amRNSForm 8.5 (EPT/RI)
31st Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
31st Jan 20228:46 amRNSForm 8.5 (EPT/RI)
31st Jan 20227:02 amRNSSensyne Health Interim Results
28th Jan 20225:07 pmRNSForm 8.3 - Sensyne Health Plc
28th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
28th Jan 20228:30 amRNSForm 8.5 (EPT/RI)
27th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
27th Jan 20228:43 amRNSForm 8.5 (EPT/RI)
26th Jan 20226:27 pmRNSPublication of Circular, Notice of General Meeting
26th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
26th Jan 202211:06 amRNSSecond Price Monitoring Extn
26th Jan 202211:00 amRNSPrice Monitoring Extension
26th Jan 20227:00 amRNSCompletion of financing, notice of General Meeting
25th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
25th Jan 20229:26 amRNSForm 8.3 - Sensyne Health Plc
24th Jan 20221:39 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.
24th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
24th Jan 20228:58 amRNSForm 8.5 (EPT/RI)
21st Jan 20221:38 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.
21st Jan 202212:00 pmRNSPeel Hunt LLP – FORM 8.5 (EPT/RI)
21st Jan 20228:59 amRNSForm 8.5 (EPT/RI)
21st Jan 20228:23 amRNSForm 8.3 - Sensyne Health Plc
20th Jan 20223:00 pmBUSForm 8.3 - SENS LN
20th Jan 20222:47 pmBUSForm 8.3 - SENS LN - Amendment
20th Jan 20221:13 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.